First-Principles Models of Polymorphism of Pharmaceuticals: Maximizing the Accuracy-to-Cost Ratio.

Note that molecules containing 15–20 nonhydrogen atoms were selected as targets in this work so that our computational models could be tested directly for real API materials. Although there are definitely significantly larger API molecules in the market, such constraints on the molecular size enabled us to retain the computational cost of our benchmark within an affordable range.

also in 17 other papers